505 related articles for article (PubMed ID: 10458827)
1. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
2. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
3. Dendritic interstitial and myofibroblastic cells at the border of salivary gland tumors.
Soma L; LiVolsi VA; Baloch ZW
Arch Pathol Lab Med; 2001 Feb; 125(2):232-6. PubMed ID: 11175641
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
Foschini MP; Krausz T
Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
[TBL] [Abstract][Full Text] [Related]
5. [Myoepithelial differentiation markers in salivary gland neoplasia].
Scarpellini F; Marucci G; Foschini MP
Pathologica; 2001 Dec; 93(6):662-7. PubMed ID: 11785118
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of vimentin, calponin and HHF-35 in salivary gland tumors.
Cavalcante RB; Lopes FF; Ferreira AS; Freitas Rde A; de Souza LB
Braz Dent J; 2007; 18(3):192-7. PubMed ID: 18176708
[TBL] [Abstract][Full Text] [Related]
7. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
[TBL] [Abstract][Full Text] [Related]
8. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation.
Foschini MP; Marucci G; Eusebi V
Virchows Arch; 2002 May; 440(5):536-42. PubMed ID: 12021929
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of three novel smooth muscle-specific proteins in salivary gland pleomorphic adenoma: assessment of the morphogenetic role of myoepithelium.
Savera AT; Gown AM; Zarbo RJ
Mod Pathol; 1997 Nov; 10(11):1093-100. PubMed ID: 9388059
[TBL] [Abstract][Full Text] [Related]
10. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
[TBL] [Abstract][Full Text] [Related]
11. Application of immunohistochemistry to the diagnosis of salivary gland tumors.
de Araújo VC; de Sousa SO; Carvalho YR; de Araújo NS
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):195-202. PubMed ID: 10981871
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of the Ca(2+)-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors.
Huang JW; Ming Z; Shrestha P; Mori M; Ilg E; Schäfer BW; Heizmann CW
J Oral Pathol Med; 1996 Nov; 25(10):547-55. PubMed ID: 8986967
[TBL] [Abstract][Full Text] [Related]
13. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
Meer S; Altini M
Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
[TBL] [Abstract][Full Text] [Related]
15. Myoepithelial cells in salivary gland tumors. An immunohistochemical study.
Kahn HJ; Baumal R; Marks A; Dardick I; van Nostrand AW
Arch Pathol Lab Med; 1985 Feb; 109(2):190-5. PubMed ID: 2579620
[TBL] [Abstract][Full Text] [Related]
16. Keratin 14 immunoreactive cells in pleomorphic adenomas and adenoid cystic carcinomas of salivary glands.
Ogawa Y; Toyosawa S; Ishida T; Ijuhin N
Virchows Arch; 2000 Jul; 437(1):58-68. PubMed ID: 10963381
[TBL] [Abstract][Full Text] [Related]
17. Human kallikrein 8 expression in salivary gland tumors.
Darling MR; Tsai S; Jackson-Boeters L; Daley TD; Diamandis EP
Head Neck Pathol; 2008 Sep; 2(3):169-74. PubMed ID: 20614312
[TBL] [Abstract][Full Text] [Related]
18. GATA3 immunohistochemical expression in salivary gland neoplasms.
Schwartz LE; Begum S; Westra WH; Bishop JA
Head Neck Pathol; 2013 Dec; 7(4):311-5. PubMed ID: 23604756
[TBL] [Abstract][Full Text] [Related]
19. MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue.
Mannweiler S; Beham A; Langner C
APMIS; 2003 Oct; 111(10):978-84. PubMed ID: 14616551
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactive tenascin in tumours of salivary glands: evidence for enhanced expression in tumour stroma and production by tumour cells.
Shrestha P; Sumitomo S; Ogata K; Yamada K; Takai Y; Yang L; Mori M
Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):393-9. PubMed ID: 7536507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
